HomeVVOS • NASDAQ
add
Vivos Therapeutics Inc
Previous close
$4.37
Day range
$4.20 - $5.14
Year range
$1.91 - $9.14
Market cap
29.92M USD
Avg Volume
247.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.86M | 16.93% |
Operating expense | 4.98M | -7.57% |
Net income | -2.62M | -24.99% |
Net profit margin | -67.77 | -6.88% |
Earnings per share | -0.40 | 87.03% |
EBITDA | -2.50M | 28.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.31M | 538.77% |
Total assets | 15.35M | 48.75% |
Total liabilities | 7.68M | -25.21% |
Total equity | 7.66M | — |
Shares outstanding | 4.84M | — |
Price to book | 2.71 | — |
Return on assets | -42.40% | — |
Return on capital | -75.92% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.62M | -24.99% |
Cash from operations | -4.19M | -49.54% |
Cash from investing | -192.00K | -24.68% |
Cash from financing | 3.79M | — |
Net change in cash | -592.00K | 79.96% |
Free cash flow | -3.26M | -9.89% |
About
Founded
2016
Headquarters
Website
Employees
119
